###################################################################################################################################################################
#Enrichment results using 'Cellular Component from Gene Ontology (GO)', created by dcGO Enrichment at 16/06/2016 14:19:38 (day/month/year hour:min:sec)
#Citation: Fang H, Gough J. (2012) dcGO: database of domain-centric ontologies on functions, phenotypes, diseases and more. Nucleic Acids Res (PubMed ID: 23161684)
###################################################################################################################################################################
#
#'GroupID' column: group id (by default 'Group' for single group);
#'GO ID' column: the identifier of ontological terms;
#'GO term' column: the name of ontological terms;
#'xxxx (four levels)' column: term specificity (only appear when using slim version of the ontology; 1 for highly general, 2 for general, 3 for specific, and 4 for highly specific);
#'Z-score' column: Z-score being calculated based on hypergeometric distribution;
#'P-value' column: P-value being calculated based on hypergeometric distribution;
#'FDR' column: FDR used to assess the statistical significance of term enrichments;
#'#Domains (Overlaps|Group|Term|Background)' column: the number of domains, i.e., 'Overlaps' for the number of domains in the input group but also being annotated by the term; 'Group' for the number of domains in the input group (also annotatable by the ontology); 'Term' for the number of domains being annotated by the term; 'Backgroud' for the number of domains that are annotatable by the ontology.
#'Annotated domains' column: a list of semicolon-separated domains in the input group but also being annotated by the term.
#
GroupID	GO ID	GO term	PFAM slim (four levels)	Z-score	P-value	FDR	#Domains (Overlaps|Group|Term|Background)	Annotated domains
Group	GO:0044425	membrane part	1	7.08	1.12e-11	1.76e-09	122|283|688|2675	PF00020;PF00027;PF00041;PF00057;PF00059;PF00063;PF00085;PF00086;PF00094;PF00106;PF00122;PF00130;PF00168;PF00169;PF00254;PF00307;PF00349;PF00350;PF00373;PF00400;PF00413;PF00435;PF00452;PF00515;PF00534;PF00535;PF00564;PF00611;PF00622;PF00675;PF00689;PF00690;PF00702;PF00754;PF00757;PF00789;PF00884;PF00928;PF00969;PF01030;PF01044;PF01064;PF01066;PF01145;PF01179;PF01217;PF01302;PF01335;PF01369;PF01391;PF01392;PF01403;PF01412;PF01433;PF01437;PF01471;PF01496;PF01553;PF01562;PF01602;PF01663;PF01699;PF01826;PF01833;PF02177;PF02181;PF02210;PF02214;PF02225;PF02263;PF02434;PF02518;PF02828;PF02931;PF02985;PF03062;PF03810;PF03921;PF04116;PF04389;PF04810;PF05020;PF05021;PF05193;PF05790;PF06367;PF06371;PF07645;PF07647;PF07651;PF07653;PF07654;PF07679;PF07686;PF07690;PF08389;PF08416;PF08515;PF08736;PF08742;PF09058;PF09379;PF09380;PF10409;PF10600;PF10608;PF11933;PF12548;PF12710;PF12763;PF12796;PF12906;PF12924;PF12947;PF13385;PF13405;PF13426;PF13519;PF13733;PF13855;PF13903;PF13920
Group	GO:0031012	extracellular matrix	1	7.72	1.42e-10	1.11e-08	33|283|96|2675	PF00019;PF00024;PF00041;PF00045;PF00052;PF00053;PF00054;PF00057;PF00059;PF00086;PF00090;PF00093;PF00094;PF00307;PF00413;PF00683;PF00688;PF01391;PF01392;PF01421;PF01562;PF01826;PF02210;PF06119;PF07546;PF07645;PF07679;PF07686;PF08742;PF09289;PF12947;PF13385;PF13855
Group	GO:0042995	cell projection	1	6.79	5.33e-10	2.79e-08	68|283|314|2675	PF00019;PF00027;PF00041;PF00045;PF00057;PF00063;PF00130;PF00168;PF00169;PF00241;PF00254;PF00307;PF00350;PF00373;PF00400;PF00413;PF00415;PF00435;PF00611;PF00688;PF00754;PF00778;PF00780;PF01044;PF01392;PF01471;PF01477;PF02177;PF02181;PF02210;PF02214;PF02931;PF03133;PF03165;PF04048;PF06367;PF06371;PF06920;PF07534;PF07645;PF07647;PF07653;PF07679;PF07686;PF07690;PF07728;PF08232;PF08393;PF09058;PF09379;PF09380;PF10524;PF10600;PF10608;PF11933;PF12763;PF12774;PF12775;PF12780;PF12796;PF12924;PF12947;PF13405;PF13637;PF13716;PF13855;PF13857;PF14429
Group	GO:0071944	cell periphery	1	6.21	2.55e-09	1.00e-07	106|283|610|2675	PF00020;PF00027;PF00040;PF00041;PF00057;PF00059;PF00063;PF00082;PF00085;PF00086;PF00094;PF00106;PF00109;PF00122;PF00130;PF00168;PF00169;PF00241;PF00307;PF00373;PF00400;PF00435;PF00501;PF00564;PF00611;PF00622;PF00689;PF00690;PF00698;PF00702;PF00754;PF00757;PF00778;PF00780;PF00969;PF01030;PF01044;PF01064;PF01145;PF01179;PF01217;PF01301;PF01302;PF01335;PF01369;PF01391;PF01392;PF01403;PF01412;PF01433;PF01437;PF01496;PF01602;PF01699;PF01826;PF01833;PF02181;PF02210;PF02214;PF02225;PF02770;PF02771;PF02801;PF02828;PF02931;PF03921;PF03953;PF04048;PF05790;PF06046;PF06367;PF06371;PF07645;PF07647;PF07651;PF07653;PF07654;PF07679;PF07686;PF07690;PF07728;PF08393;PF08416;PF08515;PF08736;PF08742;PF09058;PF09379;PF09380;PF10409;PF10600;PF10608;PF11933;PF12763;PF12774;PF12775;PF12780;PF12796;PF12947;PF13385;PF13405;PF13426;PF13519;PF13637;PF13855;PF13903
Group	GO:0030054	cell junction	1	5.50	7.98e-07	1.39e-05	38|283|162|2675	PF00041;PF00063;PF00086;PF00130;PF00168;PF00169;PF00307;PF00350;PF00373;PF00435;PF00564;PF00611;PF00702;PF00780;PF01044;PF01145;PF01179;PF01369;PF01391;PF01412;PF02210;PF02828;PF03953;PF07645;PF07653;PF07679;PF07686;PF08416;PF08736;PF09058;PF09379;PF09380;PF10409;PF10600;PF10608;PF11933;PF12796;PF13903
Group	GO:0043234	protein complex	1	4.03	4.58e-05	4.23e-04	135|283|984|2675	PF00019;PF00027;PF00041;PF00052;PF00053;PF00054;PF00063;PF00076;PF00085;PF00086;PF00097;PF00109;PF00122;PF00149;PF00153;PF00169;PF00179;PF00240;PF00270;PF00271;PF00307;PF00373;PF00385;PF00400;PF00432;PF00435;PF00452;PF00515;PF00557;PF00583;PF00622;PF00642;PF00651;PF00675;PF00688;PF00689;PF00690;PF00698;PF00702;PF00754;PF00757;PF00778;PF00899;PF00928;PF00969;PF00989;PF01030;PF01064;PF01088;PF01145;PF01217;PF01302;PF01335;PF01336;PF01403;PF01426;PF01437;PF01448;PF01485;PF01496;PF01602;PF01751;PF01833;PF02008;PF02148;PF02198;PF02201;PF02210;PF02214;PF02269;PF02518;PF02801;PF02931;PF02985;PF03165;PF03256;PF03645;PF03810;PF03826;PF03920;PF03953;PF04048;PF04408;PF04561;PF04563;PF04762;PF04810;PF04818;PF05193;PF06046;PF06733;PF07034;PF07653;PF07654;PF07679;PF07686;PF07707;PF07728;PF08232;PF08313;PF08389;PF08393;PF08447;PF08515;PF08659;PF08662;PF08711;PF09379;PF09380;PF10608;PF11717;PF11933;PF11934;PF12765;PF12774;PF12775;PF12780;PF12796;PF12842;PF12874;PF12894;PF12895;PF13086;PF13385;PF13405;PF13426;PF13519;PF13589;PF13638;PF13639;PF13656;PF13831;PF13832;PF13855;PF14259
Group	GO:0005576	extracellular region	1	3.34	9.80e-04	5.23e-03	52|283|327|2675	PF00019;PF00024;PF00040;PF00041;PF00045;PF00049;PF00052;PF00053;PF00054;PF00057;PF00059;PF00076;PF00082;PF00086;PF00090;PF00093;PF00094;PF00307;PF00413;PF00683;PF00688;PF00754;PF00884;PF01033;PF01179;PF01391;PF01392;PF01400;PF01403;PF01421;PF01433;PF01471;PF01477;PF01562;PF01663;PF01826;PF02210;PF02263;PF04389;PF06119;PF07546;PF07645;PF07679;PF07686;PF08246;PF08742;PF09289;PF12548;PF12796;PF12947;PF13385;PF13855
Group	GO:0033267	axon part	2	7.06	1.73e-08	5.44e-07	20|283|48|2675	PF00130;PF00169;PF00254;PF00307;PF00435;PF00754;PF02181;PF02210;PF02214;PF06367;PF06371;PF07534;PF07653;PF07679;PF10600;PF10608;PF11933;PF12796;PF13637;PF13857
Group	GO:0005802	trans-Golgi network	2	6.75	9.64e-08	2.52e-06	17|283|39|2675	PF00122;PF00169;PF00611;PF00689;PF00690;PF00702;PF00928;PF01217;PF01302;PF01369;PF01465;PF01602;PF03765;PF09324;PF12783;PF12796;PF12906
Group	GO:0009986	cell surface	2	5.94	2.01e-07	4.51e-06	33|283|124|2675	PF00019;PF00020;PF00040;PF00041;PF00057;PF00059;PF00082;PF00086;PF00090;PF00094;PF00688;PF00754;PF00884;PF00969;PF01064;PF01179;PF01392;PF01421;PF01433;PF01562;PF01826;PF02210;PF02931;PF05790;PF07645;PF07654;PF07679;PF07686;PF08742;PF12548;PF12947;PF13733;PF13855
Group	GO:0031252	cell leading edge	2	6.03	3.19e-07	6.26e-06	25|283|81|2675	PF00041;PF00063;PF00130;PF00169;PF00241;PF00307;PF00373;PF00435;PF00611;PF00780;PF01044;PF01302;PF01392;PF02181;PF02210;PF02214;PF06367;PF06371;PF07653;PF07679;PF09379;PF09380;PF12763;PF13405;PF13716
Group	GO:0016327	apicolateral plasma membrane	2	5.97	1.44e-06	2.27e-05	16|283|41|2675	PF00086;PF00130;PF00169;PF00373;PF00564;PF01179;PF01369;PF02828;PF07653;PF07686;PF08736;PF09379;PF09380;PF10600;PF10608;PF13903
Group	GO:0030135	coated vesicle	2	5.36	3.86e-06	5.08e-05	23|283|80|2675	PF00063;PF00094;PF00122;PF00130;PF00168;PF00169;PF00400;PF00651;PF00928;PF01217;PF01496;PF01602;PF01826;PF03765;PF04810;PF07651;PF07653;PF07654;PF07690;PF07707;PF08742;PF12697;PF12763
Group	GO:0044431	Golgi apparatus part	2	5.26	3.88e-06	5.08e-05	27|283|103|2675	PF00082;PF00094;PF00122;PF00400;PF00535;PF00583;PF00689;PF00690;PF00702;PF00928;PF01217;PF01369;PF01562;PF01602;PF02225;PF02263;PF02434;PF04810;PF07645;PF07654;PF09324;PF12697;PF12783;PF12796;PF12906;PF13405;PF13733
Group	GO:0005768	endosome	2	5.10	5.53e-06	6.68e-05	30|283|123|2675	PF00041;PF00057;PF00082;PF00169;PF00240;PF00350;PF00757;PF00928;PF00969;PF01030;PF01064;PF01145;PF01302;PF01496;PF02204;PF02214;PF02225;PF02759;PF03765;PF04389;PF07645;PF07647;PF07654;PF08515;PF09324;PF12763;PF12783;PF12796;PF12906;PF13639
Group	GO:0045202	synapse	2	5.04	6.34e-06	7.11e-05	31|283|130|2675	PF00063;PF00130;PF00168;PF00169;PF00373;PF00435;PF00611;PF00622;PF00928;PF01217;PF01392;PF01496;PF01602;PF02177;PF02210;PF02214;PF02828;PF02931;PF07534;PF07653;PF07679;PF07690;PF08416;PF09058;PF10600;PF10608;PF12763;PF12796;PF12924;PF13385;PF13857
Group	GO:0048471	perinuclear region of cytoplasm	2	4.96	1.88e-05	1.97e-04	20|283|70|2675	PF00019;PF00122;PF00130;PF00168;PF00350;PF00583;PF00688;PF00689;PF00690;PF00702;PF01391;PF01585;PF02177;PF04810;PF06741;PF12763;PF12796;PF12924;PF13857;PF13920
Group	GO:0016323	basolateral plasma membrane	2	4.86	2.15e-05	2.11e-04	22|283|82|2675	PF00041;PF00086;PF00169;PF00307;PF00373;PF00435;PF00611;PF00757;PF01030;PF01044;PF01391;PF01412;PF08416;PF08736;PF09058;PF09379;PF09380;PF10409;PF10600;PF10608;PF12796;PF12947
Group	GO:0070160	occluding junction	2	5.15	4.90e-05	4.28e-04	10|283|23|2675	PF00086;PF01179;PF01369;PF02828;PF07653;PF08736;PF09380;PF10600;PF10608;PF13903
Group	GO:0030864	cortical actin cytoskeleton	2	4.80	1.15e-04	9.54e-04	10|283|25|2675	PF00130;PF00169;PF00241;PF00307;PF00373;PF00435;PF07651;PF07653;PF09379;PF09380
Group	GO:0005773	vacuole	2	3.98	2.11e-04	1.58e-03	30|283|147|2675	PF00057;PF00082;PF00097;PF00122;PF00168;PF00400;PF00690;PF00702;PF00780;PF00884;PF00928;PF00969;PF01145;PF01217;PF01496;PF01554;PF01699;PF02138;PF02141;PF02225;PF03455;PF04389;PF07645;PF07654;PF07690;PF08127;PF08246;PF12906;PF13639;PF13848
Group	GO:0030427	site of polarized growth	2	3.87	6.82e-04	3.82e-03	14|283|52|2675	PF00041;PF00063;PF00169;PF00254;PF00307;PF00435;PF00564;PF00611;PF02181;PF04048;PF06367;PF06371;PF07679;PF07686
Group	GO:0043235	receptor complex	2	3.47	1.82e-03	7.32e-03	14|283|57|2675	PF00041;PF00063;PF00435;PF00757;PF01030;PF01064;PF01403;PF01437;PF01833;PF02931;PF07653;PF08515;PF10608;PF13855
Group	GO:0005887	integral to plasma membrane	2	3.28	2.00e-03	7.70e-03	22|283|110|2675	PF00027;PF00041;PF00059;PF00063;PF00122;PF00435;PF00689;PF00690;PF00702;PF00754;PF01064;PF02210;PF02214;PF02931;PF07647;PF07653;PF07679;PF07686;PF08515;PF10608;PF11933;PF13426
Group	GO:0031673	H zone	3	5.82	1.23e-04	9.65e-04	4|283|4|2675	PF00122;PF00689;PF00690;PF00702
Group	GO:0005918	septate junction	3	5.24	2.25e-04	1.60e-03	5|283|7|2675	PF02828;PF07653;PF08736;PF09380;PF13903
Group	GO:0031594	neuromuscular junction	3	4.47	3.13e-04	2.14e-03	9|283|23|2675	PF00063;PF00435;PF00622;PF01392;PF02177;PF02214;PF07534;PF12924;PF13857
Group	GO:0005793	endoplasmic reticulum-Golgi intermediate compartment	3	4.75	3.88e-04	2.54e-03	6|283|11|2675	PF00122;PF00149;PF00689;PF00690;PF00702;PF13850
Group	GO:0034081	polyketide synthase complex	3	5.05	5.63e-04	3.27e-03	4|283|5|2675	PF00109;PF00698;PF02801;PF08659
Group	GO:0005890	sodium:potassium-exchanging ATPase complex	3	5.05	5.63e-04	3.27e-03	4|283|5|2675	PF00122;PF00689;PF00690;PF00702
Group	GO:0070937	CRD-mediated mRNA stability complex	3	4.78	5.48e-04	3.27e-03	5|283|8|2675	PF00076;PF00270;PF00271;PF04408;PF14259
Group	GO:0033093	Weibel-Palade body	3	5.04	1.17e-03	5.23e-03	3|283|3|2675	PF00094;PF01826;PF08742
Group	GO:0005905	coated pit	3	4.39	1.13e-03	5.23e-03	5|283|9|2675	PF00611;PF01217;PF01602;PF07651;PF12763
Group	GO:0005858	axonemal dynein complex	3	4.39	1.13e-03	5.23e-03	5|283|9|2675	PF07728;PF08393;PF12774;PF12775;PF12780
Group	GO:0005868	cytoplasmic dynein complex	3	4.18	1.20e-03	5.23e-03	6|283|13|2675	PF00400;PF03645;PF07728;PF08393;PF12774;PF12780
Group	GO:0031256	leading edge membrane	3	4.11	1.05e-03	5.23e-03	7|283|17|2675	PF00169;PF01392;PF02181;PF02214;PF06367;PF06371;PF07679
Group	GO:0005884	actin filament	3	4.11	1.05e-03	5.23e-03	7|283|17|2675	PF00063;PF00169;PF00307;PF00373;PF09379;PF09380;PF12796
Group	GO:0044224	juxtaparanode region of axon	3	4.47	1.55e-03	6.40e-03	4|283|6|2675	PF02214;PF07653;PF10600;PF10608
Group	GO:0001931	uropod	3	4.47	1.55e-03	6.40e-03	4|283|6|2675	PF00063;PF00373;PF09379;PF09380
Group	GO:0030140	trans-Golgi network transport vesicle	3	4.06	2.06e-03	7.70e-03	5|283|10|2675	PF00122;PF00928;PF01217;PF01602;PF12697
Group	GO:0008076	voltage-gated potassium channel complex	3	4.06	2.06e-03	7.70e-03	5|283|10|2675	PF00027;PF00754;PF02210;PF02214;PF13426
Group	GO:0005925	focal adhesion	3	3.60	2.16e-03	7.89e-03	9|283|29|2675	PF00041;PF00169;PF00373;PF00611;PF01044;PF08416;PF09379;PF10409;PF12796
Group	GO:0071920	cleavage body	4	5.04	1.17e-03	5.23e-03	3|283|3|2675	PF00270;PF00271;PF00622
